TABLE 1.
Parameterb | Value for group (h)
|
||||
---|---|---|---|---|---|
4 | 8 | 12 | 16 | 24 | |
No. of subjects | 5 | 6 | 5 | 5 | 5 |
Mean (cells/liter) | 9.9 × 107 | 9.5 × 107 | 9.5 × 107 | 11.5 × 107 | 12.6 × 107 |
SD (cells/liter) | 5.5 × 107 | 3.5 × 107 | 3.3 × 107 | 4.4 × 107 | 2.3 × 107 |
PMNs (%) | 2.4 ± 1.8 | 1.2 ± 1.0 | 2.8 ± 3.1 | 1.8 ± 1.5 | 1.4 ± 1.1 |
Lymphocytes (%) | 14.4 ± 3.7 | 14.7 ± 12.0 | 8.4 ± 7.4 | 16.6 ± 11.9 | 16.0 ± 6.9 |
Mono/macro (%) | 82.6 ± 3.8 | 80.2 ± 12.7 | 88.2 ± 8.2 | 81.6 ± 12.2 | 76.6 ± 17.2 |
Eosinophils (%) | 0.6 ± 0.9 | 0.8 ± 1.6 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.2 ± 0.4 |
Other cells (%) | 0.0 ± 0.0 | 0.3 ± 0.5 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.4 ± 0.9 |
Degen cells (%) | 0.0 ± 0.0 | 2.8 ± 4.3 | 0.6 ± 1.3 | 0.0 ± 0.0 | 5.4 ± 12.1 |
ELF volume (ml) | 1.2 ± 0.9 | 0.9 ± 0.3 | 1.1 ± 0.7 | 0.9 ± 0.4 | 1.0 ± 0.3 |
All data given as means ± SDs. There were no significant differences among the groups for cell recovery, differential cell count, or volume of ELF (P > 0.05). Comparison testing was not applied to zero values.
PMN, polymorphonuclear leukocyte; Mono/macro, monocytes and macrophages; Other, other unrecognizable cells; Degen, degenerated cells.